HYDROCORTISONE SODIUM SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocortisone Sodium Succinate, and what generic alternatives are available?
Hydrocortisone Sodium Succinate is a drug marketed by Abraxis Pharm, Baxter Hlthcare, Intl Medication, and Watson Labs. and is included in fourteen NDAs.
The generic ingredient in HYDROCORTISONE SODIUM SUCCINATE is hydrocortisone sodium succinate. There are sixty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone sodium succinate profile page.
Summary for HYDROCORTISONE SODIUM SUCCINATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 14 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 26 |
Patent Applications: | 3,592 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDROCORTISONE SODIUM SUCCINATE at DailyMed |
Recent Clinical Trials for HYDROCORTISONE SODIUM SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Medical Center Groningen | Early Phase 1 |
Children's Cancer Research Fund | Phase 1 |
University of Colorado, Denver | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCORTISONE SODIUM SUCCINATE
US Patents and Regulatory Information for HYDROCORTISONE SODIUM SUCCINATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 088670-001 | Jun 8, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 086619-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abraxis Pharm | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 088668-001 | Jun 8, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 084737-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Baxter Hlthcare | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 087567-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 084737-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abraxis Pharm | HYDROCORTISONE SODIUM SUCCINATE | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 088667-001 | Jun 8, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |